Skip to content
healthcare.dev

bumetanide

NDC 70771-1026, bumetanide, tablet, from Zydus Lifesciences Limited.

Product NDC
70771-1026
Status
Listed
Labeler
Zydus Lifesciences Limited
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA202900
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70771-1026 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BUMETANIDE2 mg/1

Pharmacologic classes

Increased Diuresis at Loop of Henle [PE]; Loop Diuretic [EPC]

Package NDCNDC-11Package
70771-1026-0707711026001000 TABLET in 1 BOTTLE (70771-1026-0)
70771-1026-170771102601100 TABLET in 1 BOTTLE (70771-1026-1)
70771-1026-37077110260330 TABLET in 1 BOTTLE (70771-1026-3)
70771-1026-570771102605500 TABLET in 1 BOTTLE (70771-1026-5)
70771-1026-97077110260990 TABLET in 1 BOTTLE (70771-1026-9)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/82eb62ca-c32b-4ff8-9f71-43219b240480

Use it

Look up 70771-1026 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70771-1026 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70771-1026. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.